...
首页> 外文期刊>The Journal of Infectious Diseases >Poliomyelitis Eradication in China: 1953-2012
【24h】

Poliomyelitis Eradication in China: 1953-2012

机译:中国根除脊髓灰质炎:1953-2012年

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Poliomyelitis has historically been endemic in China and has been considered an important cause of disability and death.Methods. We reviewed strategies and measures of poliomyelitis control and eradication from 1953 to 2012. Data from notifiable disease and routine immunization reporting systems and acute flaccid paralysis (AFP) surveillance were analyzed.Results. About 20 000 poliomyelitis cases were reported annually in the prevaccine era. During 1965-1977, live, attenuated oral poliomyelitis vaccine (OPV) was administered to children through annual mass campaigns in the winter, and the number of poliomyelitis cases started to decline. A cold chain system was established during 1982, and OPV coverage increased during the early stage of the Expanded Programme on Immunization, from 1978 to 1988. Between 1989 and 1999, routine immunization was strengthened, supplementary immunization activities (SIAs) were conducted, and the AFP surveillance system was established. China reported a last indigenous poliomyelitis case in 1994 and was certified as free of polio in 2000. To maintain its polio-free status, China kept >90% coverage of 3 doses of OPV, conducted SIAs in high-risk areas, and maintained high-quality of AFP surveillance. China succeeded in stopping the outbreak in Xinjiang in 2011.Conclusions. China's polio-free status was achieved and maintained through strengthening routine immunization and implementing SIAs and AFP surveillance.
机译:背景。脊髓灰质炎在中国历来是地方病,被认为是致残和死亡的重要原因。我们回顾了1953年至2012年控制和根除脊髓灰质炎的策略和措施。分析了应通报疾病和常规免疫报告系统以及急性弛缓性麻痹(AFP)监测的数据。在疫苗接种前的时期,每年报告约2万例脊髓灰质炎病例。在1965年至1977年期间,通过冬季每年一次的大规模运动向儿童注射了减毒的口服口服小儿麻痹症疫苗(OPV),小儿麻痹症病例开始减少。 1982年建立了冷链系统,1978年至1988年扩大免疫规划的早期阶段,OPV的覆盖率有所提高。1989年至1999年,常规免疫得到了加强,开展了补充免疫活动(SIA),并且建立了法新社监视系统。中国于1994年报告了最后一例原发性脊髓灰质炎病例,并于2000年被认证为无脊髓灰质炎。为保持无脊髓灰质炎状态,中国保持了3剂OPV覆盖率> 90%,在高危地区进行了SIA,并保持高水平-法新社监视的质量。中国在2011年成功地制止了新疆的爆发。通过加强常规免疫,实施SIA和AFP监测,达到并维持了中国的无脊髓灰质炎状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号